logo_image
Headline: Lifshitz Law PLLC Announces Investigations of SGEN, PRVB, KBAL, and ADAP
Location: Hewlett, NY, US
Post Date: Mar 18, 2023 8:11 PM
TAG ID: pznews438576
DocID: 202303198790725-en.xml
Word Count: approx. 363 words
 
 
Full story:
Lifshitz Law PLLC Announces Investigations of SGEN, PRVB, KBAL, and ADAP

NEW YORK, March 18, 2023 (GLOBE NEWSWIRE) -- Seagen Inc. (NASDAQ: SGEN) Lifshitz Law PLLC announces an investigation into possible breach of fiduciary duties in connection with the sale of SGEN to Pfizer Inc. for $229.00 per share in cash. If you are a SGEN investor, and would like additional information about our investigation, please complete the Information Request Form or contact Joshua Lifshitz, Esq. by telephone at (516)493-9780 or e-mail at info@lifshitzlaw.com. Provention Bio, Inc. (NASDAQ: PRVB) Lifshitz Law PLLC announces an investigation into possible breach of fiduciary duties in connection with the sale of PRVB to Sanofi S.A. for $25.00 per share in cash. If you are an PRVB investor, and would like additional information about our investigation, please complete the Information Request Form or contact Joshua Lifshitz, Esq. by telephone at (516)493-9780 or e-mail at info@lifshitzlaw.com. Kimball International, Inc. (NASDAQ: KBAL) Lifshitz Law PLLC announces an investigation into possible breach of fiduciary duties in connection with the sale of KBAL to HNI Corporation for $9.00 in cash and 0.3101 of HNI common stock for each share of Kimball common stock. If you are an KBAL investor, and would like additional information about our investigation, please complete the Information Request Form or contact Joshua Lifshitz, Esq. by telephone at (516)493-9780 or e-mail at info@lifshitzlaw.com. Adaptimmune Therapeutics PLC (NASDAQ: ADAP) Lifshitz Law PLLC announces investigation into possible breach of fiduciary duties in connection with the merger of ADAP and TCR� Therapeutics, Inc. Following the merger, pre-merger Adaptimmune shareholders are expected to own approximately 75.0% of the outstanding equity of the combined company. If you are an ADAP investor, and would like additional information about our investigation, please complete the Information Request Form or contact Joshua Lifshitz, Esq. by telephone at (516)493-9780 or e-mail at info@lifshitzlaw.com. ATTORNEY ADVERTISING.� 2023 Lifshitz Law PLLC. The law firm responsible for this advertisement is Lifshitz Law PLLC, 1190 Broadway, Hewlett, New York 11557, Tel: (516)493-9780. Prior results do not guarantee or predict a similar outcome with respect to any future matter. Contact: Joshua M. Lifshitz, Esq. Lifshitz Law PLLC Phone: 516-493-9780 Facsimile: 516-280-7376 Email: info@lifshitzlaw.com

 
Please login to download this Story